[go: up one dir, main page]

NO914710L - Fremgangsmaate for fremstilling av 2beta,19-ethylenbroede steroider som aromataseinhibitorer - Google Patents

Fremgangsmaate for fremstilling av 2beta,19-ethylenbroede steroider som aromataseinhibitorer

Info

Publication number
NO914710L
NO914710L NO91914710A NO914710A NO914710L NO 914710 L NO914710 L NO 914710L NO 91914710 A NO91914710 A NO 91914710A NO 914710 A NO914710 A NO 914710A NO 914710 L NO914710 L NO 914710L
Authority
NO
Norway
Prior art keywords
aromatase inhibitors
ethylenebroid
2beta
steroids
procedure
Prior art date
Application number
NO91914710A
Other languages
English (en)
Other versions
NO180304C (no
NO180304B (no
NO914710D0 (no
Inventor
John O'neal Johnston
Norton Paul Peet
Joseph Paul Burkhart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO914710D0 publication Critical patent/NO914710D0/no
Publication of NO914710L publication Critical patent/NO914710L/no
Publication of NO180304B publication Critical patent/NO180304B/no
Publication of NO180304C publication Critical patent/NO180304C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO914710A 1990-11-30 1991-11-29 Analogifremgangsmåte for fremstilling av terapeutisk aktivt 2<beta>,19-(ethylen)androst-4-en-3,17-dion NO180304C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,184 US5166201A (en) 1990-11-30 1990-11-30 2β,19-ethylene bridged steroids as aromatase inhibitors

Publications (4)

Publication Number Publication Date
NO914710D0 NO914710D0 (no) 1991-11-29
NO914710L true NO914710L (no) 1992-06-01
NO180304B NO180304B (no) 1996-12-16
NO180304C NO180304C (no) 1997-04-02

Family

ID=24489093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914710A NO180304C (no) 1990-11-30 1991-11-29 Analogifremgangsmåte for fremstilling av terapeutisk aktivt 2<beta>,19-(ethylen)androst-4-en-3,17-dion

Country Status (20)

Country Link
US (1) US5166201A (no)
EP (1) EP0488383B1 (no)
JP (1) JP3143876B2 (no)
KR (1) KR100190776B1 (no)
CN (1) CN1033975C (no)
AT (1) ATE142639T1 (no)
AU (1) AU635444B2 (no)
CA (1) CA2056638C (no)
DE (1) DE69122048T2 (no)
DK (1) DK0488383T3 (no)
ES (1) ES2094183T3 (no)
FI (1) FI102073B (no)
GR (1) GR3021981T3 (no)
HU (1) HU210830B (no)
IE (1) IE914168A1 (no)
IL (1) IL100196A (no)
NO (1) NO180304C (no)
NZ (1) NZ240738A (no)
PT (1) PT99661B (no)
ZA (1) ZA919296B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627756A (en) * 1970-04-23 1971-12-14 Searle & Co N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Also Published As

Publication number Publication date
DE69122048D1 (de) 1996-10-17
HU210830B (en) 1995-08-28
IL100196A (en) 1996-03-31
JPH04290898A (ja) 1992-10-15
AU8812891A (en) 1992-06-04
IL100196A0 (en) 1992-08-18
FI915623A0 (fi) 1991-11-28
DK0488383T3 (da) 1996-09-30
GR3021981T3 (en) 1997-03-31
AU635444B2 (en) 1993-03-18
US5166201A (en) 1992-11-24
IE914168A1 (en) 1992-06-03
DE69122048T2 (de) 1997-02-20
NO180304C (no) 1997-04-02
FI102073B1 (fi) 1998-10-15
ES2094183T3 (es) 1997-01-16
FI102073B (fi) 1998-10-15
KR100190776B1 (ko) 1999-06-01
KR920009842A (ko) 1992-06-25
CA2056638C (en) 2002-03-05
JP3143876B2 (ja) 2001-03-07
NO180304B (no) 1996-12-16
FI915623L (fi) 1992-05-31
CA2056638A1 (en) 1992-05-31
HUT59937A (en) 1992-07-28
PT99661A (pt) 1992-10-30
EP0488383B1 (en) 1996-09-11
HU913739D0 (en) 1992-02-28
EP0488383A1 (en) 1992-06-03
NZ240738A (en) 1993-11-25
ZA919296B (en) 1992-08-26
PT99661B (pt) 1999-05-31
NO914710D0 (no) 1991-11-29
CN1061974A (zh) 1992-06-17
ATE142639T1 (de) 1996-09-15
CN1033975C (zh) 1997-02-05

Similar Documents

Publication Publication Date Title
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
ES529811A0 (es) Procedimiento para preparar derivados de n-fenil-benzamida
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
NO914710L (no) Fremgangsmaate for fremstilling av 2beta,19-ethylenbroede steroider som aromataseinhibitorer
DE68911157D1 (de) Synthese von 6-Methylenandrosta-1,4-dien-3,17-dion-Derivate.
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK0559706T3 (da) 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.
ES2077867T3 (es) 3-carbamoil-4-hidroxicumarinas antihelminticas y anticoccidiales, procedimiento de uso y composiciones.
ES2100315T3 (es) Nuevos esteroides 16-metilo sustituidos derivados de la pregna-1,4-dieno-3,20-diona, su preparacion, su aplicacion a la preparacion de esteroides 16-metileno y nuevos productos intermedios.
MXPA03000845A (es) Estrogenos substituidos por 16alfa-metilo o etilo.
NO911236L (no) Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer.
CA2032311A1 (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors
DK146007C (da) Analogifremgangsmaade til fremstilling af d-homosteroider
DK14083A (da) Analogifremgangsmaade til fremstilling af derivater af 4-desacetyl-vincaleucoblastin-c-3-carboxhydrazid
JPS52131580A (en) N-substituted pyridinium-2-sulfonylimines, containing same as active ingredient
ECSP951417A (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicación como medicamentos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2001